BioPharmSignal logoBioPharmSignal

Biotech News

Neuronetics and Jorey Chernett Announce Shared Vision

Neuronetics (STIM)NeuroneticsCompany update

Chernett Affirms Comfort with the Company’s Capital Position and Confidence in Management’s Execution Establishes Path Towards Neuronetics Board Representation MALVERN, Pa., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics” or the “Company”) and Jorey Chernett, the

Related news

STIMNeuronetics2026-07-28 12:30 EST

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

STIMNeuronetics2026-07-06 12:30 EST

Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026

ATRCAtriCure2026-07-02 12:00 EST

AtriCure to Announce Second Quarter 2026 Financial Results

RXSTRxSight2026-08-05 20:05 EST

RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook

SGHTSight Sciences2026-08-05 20:04 EST

Sight Sciences Announces Aetna Coverage for OMNI and SION Surgical Systems

View all latest news

Neuronetics

Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy. NeuroStar Advanced Therapy NeuroStar uses...

Recent company news

STIMNeuronetics2026-08-03 12:00 EST

Neuronetics and Jorey Chernett Announce Shared Vision

STIMNeuronetics2026-07-31 21:00 EST

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

STIMNeuronetics2026-07-28 12:32 EST

Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland

STIMNeuronetics2026-07-28 12:30 EST

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

STIMNeuronetics2026-07-20 20:05 EST

Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

Stock data

Close
2.25 USD
Market cap
108.56M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States